公开(公告)号：US20190298791A1

公开(公告)日：2019-10-03

申请号：US16210343

申请日：2018-12-05

Applicant: Yoshiteru SHIMOIDE

Inventor： Yoshiteru SHIMOIDE

IPC: A61K36/718 ,  A61K36/284 ,  A61K36/484 ,  A61K36/076 ,  A61K36/54 ,  A61P13/10 ,  A61P13/12 ,  A61P1/10 ,  A61P25/28

Abstract: Provided is a kampo medicine for treating multimorbidity of Alzheimer-type dementia or mild cognitive impairment and at least one disease from the group consisting of overactive bladder, constipation, and chronic kidney disease with one drug. A kampo medicine for treating multimorbidity with one drug, comprising a drug combination of orengedokuto and ryokeijutsukanto as an active ingredient, wherein the kampo medicine improves a cognitive function in Alzheimer-type dementia or mild cognitive impairment and relieves and treats at least one disease from overactive bladder, constipation, and chronic kidney disease complicated by Alzheimer-type dementia or mild cognitive impairment at a high rate with one drug.

公开(公告)号：US20200164017A1

公开(公告)日：2020-05-28

申请号：US16777534

申请日：2020-01-30

Applicant: Yoshiteru SHIMOIDE

Inventor： Yoshiteru SHIMOIDE

IPC: A61K36/718 ,  A61K36/756 ,  A61K36/539 ,  A61K36/744 ,  A61K36/488 ,  A61K36/54 ,  A61K36/484 ,  A61K36/284 ,  A61K36/076 ,  A61P13/12 ,  A61P13/10 ,  A61P1/10 ,  A61P25/28

Abstract: Provided is a kampo medicine for treating multimorbidity of Alzheimer-type dementia or mild cognitive impairment and at least one disease from the group consisting of overactive bladder, constipation, and chronic kidney disease with one drug. A kampo medicine for treating multimorbidity with one drug, comprising a drug combination of orengedokuto and ryokeijutsukanto as an active ingredient, wherein the kampo medicine improves a cognitive function in Alzheimer-type dementia or mild cognitive impairment and relieves and treats at least one disease from overactive bladder, constipation, and chronic kidney disease complicated by Alzheimer-type dementia or mild cognitive impairment at a high rate with one drug.